Institutional Ownership
Fennec Pharmaceuticals Inc
CUSIP 31447P100COMFENCQ1 2026
13D / 13G Filings
17
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
16.2%
Max % of class reported
Institutional Holders
87
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
17 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Sonic Fund II, L.P. | 13G/A | 8.2% | 2.80M | SEC |
| 2 | Feb 11, 2026 | Rosalind Advisors, Inc. | 13G/A | 9.8% | 2.75M | SEC |
| 3 | Jan 14, 2026 | Southpoint Master Fund, LP | 13G/A | 8.0% | 2.74M | SEC |
| 4 | Nov 13, 2025 | Rosalind Advisors, Inc. | 13G | 7.5% | 2.08M | SEC |
| 5 | Feb 14, 2025 | Solas Capital Management, LLC | 13G/A | 8.2% | 2.25M | SEC |
| 6 | Feb 14, 2025 | Dg Capital Management, LLC | 13G/A | 4.1% | 1.11M | SEC |
| 7 | Nov 14, 2024 | Solas Capital Management, LLC | 13G/A | 7.0% | 1.92M | SEC |
| 8 | Nov 12, 2024 | Dg Capital Management, LLC | 13G/A | 5.5% | 1.52M | SEC |
| 9 | Jun 27, 2024 | Dg Capital Management, LLC | 13G | 5.2% | 1.42M | SEC |
| 10 | Feb 14, 2024 | Solas Capital Management, LLC | 13G | 5.2% | 1.38M | SEC |
7 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Fennec Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rosalind Advisors, Inc. | 2.91M | $17.89M |
| 2 | Southpoint Capital Advisors LP | 2.74M | $16.88M |
| 3 | Solas Capital Management, LLC | 2.48M | $15.27M |
| 4 | Aigh Capital Management LLC | 1.98M | $12.19M |
| 5 | Blackrock, Inc. | 1.37M | $8.41M |
| 6 | Awm Investment Company, Inc. | 720.1K | $4.43M |
| 7 | Geode Capital Management, LLC | 371.7K | $2.29M |
| 8 | State Street Corp | 359.1K | $2.21M |
| 9 | Potomac Capital Management, Inc. | 224.4K | $1.38M |
| 10 | Morgan Stanley | 211.1K | $1.30M |